Fungal infections in the recipients of solid organ transplantation

Nina Singh1

  • 1Infectious Disease Section, Veterans Affairs Medical Center, University of Pittsburgh, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, USA. nis5+@pitt.edu

Insights

Opportunistic mycoses are a major cause of death in organ transplant recipients. Emerging trends show non-Aspergillus mycelial fungi are increasingly important pathogens in these vulnerable patients.

Area of Science:

  • Medical Mycology
  • Transplantation Infectious Diseases
  • Immunocompromised Host Infections

Background:

  • Effective antibacterial and antiviral therapies have shifted mortality causes in organ transplant recipients towards opportunistic mycoses.
  • Candida and Aspergillus species have historically dominated invasive fungal infections post-transplantation.
  • Recent epidemiological shifts highlight the growing importance of non-Aspergillus mycelial fungi as pathogens.

Purpose of the Study:

  • To review the epidemiology, clinical manifestations, pathogenesis, diagnosis, and management of invasive fungal infections in organ transplant recipients.
  • To contextualize these infections within emerging trends and recent developments.
  • To provide an updated perspective on a critical area of transplant infectious disease.

Main Methods:

  • Review of epidemiological data on fungal infections in organ transplant recipients.
  • Analysis of clinical case studies and literature on emerging fungal pathogens.
  • Synthesis of current knowledge on diagnosis and management strategies.
  • Focus on recent trends and new developments in the field.

Main Results:

  • Opportunistic mycoses are a principal cause of infection-related mortality in organ transplant recipients.
  • While Candida and Aspergillus remain significant, other mycelial fungi are emerging as key pathogens.
  • Understanding these evolving trends is crucial for effective patient management.

Conclusions:

  • Invasive fungal infections remain a significant challenge in organ transplantation.
  • The landscape of fungal pathogens is changing, necessitating updated diagnostic and therapeutic approaches.
  • Continued research and vigilance are required to combat emerging fungal threats in transplant recipients.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...